Anavex Life Sciences (AVXL) news
Recent news
Anavex Life Sciences Q3 EPS $0.08
AInvest Wire · 6d agoAnavex Life Sciences 3Q net income $7.82M vs. loss $13.2M y/y
Anavex Life Sciences Corp. (Nasdaq: AVXL) reported a net income of $7.82 million for the third quarter of fiscal 2026, marking a significant turnaround from a net loss of $13.2 million in the same period of the previous year. The company’s financial performance reflects progress in its clinical…
AInvest Wire · 6d agoAnavex Life Sciences 3Q EPS 8.0C vs. loss/shr 16C y/y
Anavex Life Sciences Corp. (Nasdaq: AVXL) reported a net loss of $13.2 million, or $0.16 per share, for the third quarter of fiscal 2025, representing a slight increase in the loss per share compared to fiscal 2024 loss of $0.14 . The company’s earnings per share (EPS) for the quarter fell short of…
AInvest Wire · 6d agoAnavex Life urges holders vote 'for' its six director nominees
AInvest Wire · Aug 11, 2026Anavex Life Sciences Corp. delays 10-Q filing
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.